National Bank of Canada
FENC icon

National Bank of Canada’s Fennec Pharmaceuticals FENC Stock Holding History

National Bank of Canada’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.16K Buy
+141
New +$1.15K ﹤0.01% 2697
2026
Q1 		– Sell
-97
Closed -$747 – 3044
2025
Q4 		$747 Sell
97
-89
-48% -$731 ﹤0.01% 2656
2025
Q3 		$1.84K Buy
186
+122
+191% +$1.06K ﹤0.01% 2600
2025
Q2 		$531 Buy
64
+61
+2,033% +$417 ﹤0.01% 2760
2025
Q1 		$18 Buy
+3
New +$19 ﹤0.01% 2779

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

National Bank of Canada's FENC Position: Q2 2026 in Review

National Bank of Canada opened a new position in Fennec Pharmaceuticals (FENC) in Q2 2026: 141 shares worth $2.16K. The stake represents ﹤0.01% of the portfolio and ranks #2697 among its holdings. This is a return to the name: National Bank of Canada previously reported a position in FENC as recently as Q4 2025.

National Bank of Canada first reported a position in FENC in Q1 2025 and has held it in 5 quarters since. 104 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • National Bank of Canada held 141 shares of Fennec Pharmaceuticals worth $2.16K as of Q2 2026.
  • Fennec Pharmaceuticals was a new National Bank of Canada position in Q2 2026.
  • Fennec Pharmaceuticals made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #2697 holding.
  • National Bank of Canada first reported a position in Fennec Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • 104 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.